Taro-Sunitinib 12.5 mg

Taro-Sunitinib 12.5 mg capsules are a pharmaceutical product used in cancer treatment. This medication is designed to target specific proteins involved in cancer cell growth.

Taro-Sunitinib 12.5 mg capsules are primarily used in the treatment of certain types of cancer. Sunitinib, the active ingredient, works by inhibiting specific proteins that promote cancer cell growth. This medication is often prescribed for advanced or metastatic cancers, helping to slow the progression of the disease. Patients should consult their healthcare provider to understand the specific uses of sunitinib malate in their treatment plan.

Common effects of Taro-Sunitinib 12.5 mg capsules may include fatigue, nausea, and diarrhea. Some patients may also experience changes in blood pressure or skin discoloration. These effects can vary widely among individuals, and not everyone will experience the same symptoms. It is important to monitor any side effects and discuss them with a healthcare professional.

Taro-Sunitinib 12.5 mg capsules should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Always follow the instructions provided by your healthcare provider regarding the administration and storage of this medication. Do not share this medication with others, even if they have similar symptoms.

Taro-Sunitinib 12.5 mg capsules may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Certain foods and beverages, such as grapefruit juice, may also interact with sunitinib malate and should be avoided.